Company profile
Arialys Therapeutics company profile
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.
Business identity
- Website
- https://www.arialysrx.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2022-01-01, Year
Headquarters
- Headquarters
- San Diego, California, United States
- Country code
- US
- Continent
- North America